EUVIMEDOpdag EUVIMED
Crossref

Osteoglycin Inhibits the Progression of Lung Adenocarcinoma by Modulating ICAM1‐Mediated Cell Adhesion via the PI3K/AKT Pathway

Shangwei Xu iD, Chunji Chen, Hongwei Liu, Shuai Jiang, Zheng Li, Yun Wu

Molecular Carcinogenesis · 2025

DOI: 10.1002/mc.70007 ↗

At a glance

Journal article in Molecular Carcinogenesis, 2025. Written by Shangwei Xu and 5 co-authors. Institution: Department of Thoracic Surgery, Huadong Hospital Affiliated to Fudan University, Shanghai, China. Major MEDLINE topics: Adenocarcinoma of Lung, Proto-Oncogene Proteins c-akt, Lung Neoplasms, Phosphatidylinositol 3-Kinases. Cited 1 times so far (Crossref); 45 references. Funded by: This study was supported by Huadong Hospital Affiliated to Fudan University, Wu Jieping Medical Foundation and National Nature Cultivation Youth Project..

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Lung cancer is characterized by high aggressiveness and lethality, processing in‐depth molecular mechanism investigation is particularly necessary. In our study, we found that osteoglycin (OGN) deficiency is strongly associated with a poor prognosis in lung adenocarcinoma (LUAD). OGN overexpression could inhibit the proliferation, migration, and invasion of LUAD cells. Through transcriptome sequencing analysis and experimental validation, we revealed that such OGN ‐mediated tumor suppression effect was related to cell adhesion function induced by ICAM1 downregulation, along with regulation by the PI3K/AKT signaling pathway. The present study demonstrated the specific mechanism of OGN involvement in LUAD progression, providing new evidence and potential targets for research on cancer suppression in LUAD.

Subjects

MeSH terms (MEDLINE)

Adenocarcinoma of LungProto-Oncogene Proteins c-aktLung NeoplasmsPhosphatidylinositol 3-KinasesIntercellular Adhesion Molecule-1HumansCell AdhesionSignal TransductionCell ProliferationGene Expression Regulation, NeoplasticCell MovementDisease ProgressionPrognosisCell Line, TumorAnimalsMiceMaleFemale

Author keywords

cell adhesionlung adenocarcinomametastasisosteoglycin (OGN)

Substances

Proto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesIntercellular Adhesion Molecule-1ICAM1 protein, human

Authors and institutions

  • Department of Thoracic Surgery, Huadong Hospital Affiliated to Fudan University, Shanghai, China.
  • Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Department of Respiratory Medicine, Shanghai Fengxian District Central Hospital, Shanghai, China.

ORCID profiles: Shangwei Xu

Funding

  • This study was supported by Huadong Hospital Affiliated to Fudan University, Wu Jieping Medical Foundation and National Nature Cultivation Youth Project.

Cite

APA

Xu, S., Chen, C., Liu, H., Jiang, S., Li, Z., & Wu, Y. (2025). Osteoglycin Inhibits the Progression of Lung Adenocarcinoma by Modulating ICAM1‐Mediated Cell Adhesion via the PI3K/AKT Pathway. Molecular Carcinogenesis. https://doi.org/10.1002/mc.70007

Vancouver

Xu S, Chen C, Liu H, Jiang S, Li Z, Wu Y. Osteoglycin Inhibits the Progression of Lung Adenocarcinoma by Modulating ICAM1‐Mediated Cell Adhesion via the PI3K/AKT Pathway. Molecular Carcinogenesis. 2025. doi:10.1002/mc.70007

BibTeX
@article{Xu2025,
  author = {Xu, Shangwei and Chen, Chunji and Liu, Hongwei and Jiang, Shuai and Li, Zheng and Wu, Yun},
  title = {Osteoglycin Inhibits the Progression of Lung Adenocarcinoma by Modulating ICAM1‐Mediated Cell Adhesion via the PI3K/AKT Pathway},
  journal = {Molecular Carcinogenesis},
  year = {2025},
  doi = {10.1002/mc.70007}
}
Start for free →